Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Korro Bio's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $169.91 Mil. Korro Bio's Total Assets for the quarter that ended in Dec. 2023 was $221.66 Mil.
The historical rank and industry rank for Korro Bio's Equity-to-Asset or its related term are showing as below:
KRRO'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.34 Med: -0.33 Max: 0.77
Current: 0.77
During the past 3 years, the highest Equity to Asset Ratio of Korro Bio was 0.77. The lowest was -1.34. And the median was -0.33.
KRRO's Equity-to-Asset is ranked better than 63.64% of 1565
companies
in the Biotechnology industry
Industry Median: 0.66
vs KRRO: 0.77
Korro Bio Equity-to-Asset Historical Data
The historical data trend for Korro Bio's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Korro Bio Equity-to-Asset Chart
Korro Bio Annual Data
Trend
Dec21
Dec22
Dec23
Equity-to-Asset
-0.33
-1.34
0.77
Korro Bio Semi-Annual Data
Dec21
Jun22
Dec22
Jun23
Dec23
Equity-to-Asset
-0.33
-
-1.34
-1.24
0.77
Competitive Comparison of Korro Bio's Equity-to-Asset
For the Biotechnology subindustry, Korro Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Korro Bio's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Korro Bio's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Korro Bio's Equity-to-Asset falls into.
Korro Bio Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Korro Bio's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Korro Bio (NAS:KRRO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Korro Bio Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Korro Bio's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRRO has been successfully added to your